Boston Scientific falls as cyberattack disruption hits 2026 outlook
-5.90% to $44.98 from $47.80
What moved BSX
- Boston Scientific said it is unlikely to meet its previously issued third-quarter and full-year 2026 sales and adjusted-profit forecasts after a cybersecurity incident disrupted global operations.
- Unauthorized IT activity, first identified August 25, caused a network outage that disrupted manufacturing and the processing and shipment of customer orders.
- The company had previously guided to 2026 adjusted earnings of $3.28 to $3.32 per share and net sales growth of 5.5% to 6.5%.
- Boston Scientific said major distribution centers are shipping at or above normal levels and manufacturing has resumed at most facilities, though the full financial impact remains uncertain.
- Shares slipped more than 2% following the update.
Sources: BNN Bloomberg · CNBC